Xeris Biopharma Holdings, Inc. (XERS) Stock Tumbling in Aftermarket, Here’s What you Should Know.
Xeris Biopharma Holdings, Inc. (XERS) is an innovative biotherapeutics company. The company is engaged in the development and marketing of treatments for patients with gastroenterological, neurological, and endocrinological issues. The lead product of the company includes Gvoke and Keveyis used for treating severe hypoglycemia and primary periodic paralysis respectively. The price of XERS stock during […]